{"id":"W2169210165","doi":"10.1182/blood-2012-09-451872","title":"A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research; Juravinski Cancer Centre; BC Cancer Agency; Dr. H. Bliss Murphy Cancer Centre; Hôpital de l'Enfant-Jésus; McGill University; Hôpital Maisonneuve-Rosemont; CancerCare Manitoba; Saint John Regional Hospital; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute","keywords":"Medicine; Prednisone; Thalidomide; Hazard ratio; Surgery; Multiple myeloma; Internal medicine; Maintenance therapy; Transplantation; Randomized controlled trial; Autologous stem-cell transplantation; Clinical endpoint; Confidence interval; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002564219,0.001346135,0.002555477,0.0003892951,0.0005542414,0.000968649,0.0007852637,0.001499936,0.003831017],"category_scores_gemma":[0.002293412,0.0004239342,0.002332643,0.0004700101,0.0009584361,0.0006132363,0.0003859626,0.002535705,0.000501823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001417386,"about_ca_system_score_gemma":0.002008843,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004039052,"about_ca_topic_score_gemma":0.008123786,"domain_scores_codex":[0.9989944,0.0006433543,0.00003999387,0.0001315488,0.00006876799,0.0001219448],"domain_scores_gemma":[0.9987429,0.0003407226,0.0003456131,0.0001031571,0.00008522193,0.000382445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9819141,0.002807587,0.0009265772,0.0003106931,0.0008805195,0.00003516816,0.00003872418,0.0003338359,0.001007697,0.0001017411,0.0008425309,0.01080081],"study_design_scores_gemma":[0.9772052,0.02034009,0.001469131,0.00001802665,0.0002337476,0.00002089749,0.000007529836,0.0002234211,0.00008321532,0.0000876209,0.000305581,0.000005575137],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9812033,0.007903649,0.0006362384,0.0013849,0.0005586274,0.005137902,0.001459831,0.0001031226,0.001612463],"genre_scores_gemma":[0.9820812,0.002413348,0.001871671,0.00198673,0.0004737117,0.007497735,0.001707168,0.00001905191,0.001949384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.995961,"threshold_uncertainty_score":0.01356107,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06801261865729823,"score_gpt":0.4037691003261362,"score_spread":0.335756481668838,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}